There are 749 resources available
Advances in the management of the NK-T cell lymphomas
Presenter: Won Seog Kim
Session: New advances in frequent lymphomas
Resources:
Slides
Webcast
Immune checkpoint inhibition and biomarkers in HNSCC
Presenter: Lisa Licitra
Session: Immuno-oncology
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: Olivia Pagani
Session: Management of young patients with residual disease after preoperative chemotherapy
Resources:
Slides
Webcast
Integrating PARP inhibition
Presenter: Mansoor Raza Mirza
Session: Precision medicine in ovarian and endometrial cancer
Resources:
Slides
Webcast
Novel treatments – immunotherapy and beyond
Presenter: Sandro Pignata
Session: Precision medicine in ovarian and endometrial cancer
Resources:
Slides
Webcast
What is new in the classification and management of DLBCL in 2019
Presenter: Koji Izutsu
Session: New advances in frequent lymphomas
Resources:
Slides
Webcast
Beyond immune checkpoint inhibition
Presenter: Sjoukje Oosting
Session: Immuno-oncology
Resources:
Slides
Webcast
KEYNOTE-181: Pembrolizumab vs chemotherapy in patients (pts) with advanced/metastatic adenocarcinoma (AC) or squamous cell carcinoma (SCC) of the esophagus as second-line (2L) therapy
Presenter: Sung-Bae Kim
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast
Pembrolizumab + chemotherapy for advanced G/GEJ adenocarcinoma (GC): The phase III KEYNOTE-062 study
Presenter: Hyun Cheol Chung
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast
Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC): Phase III POLO trial
Presenter: Do-Youn Oh
Session: Mini Oral session - Gastrointestinal tumours
Resources:
Slides
Webcast